HIV Virus Current Events | HIV Virus News | 9
|
| Page
9 of
73 |
1455 Results |
|
|
|
Sort By:
Page Views | Date |
New Synthetic Molecules Trigger Immune Response to HIV and Prostate Cancer
Researchers at Yale University have developed synthetic molecules capable of enhancing the body's immune response to HIV and HIV-infected cells, as well as to prostate cancer cells. Their findings, published online in the Journal of the American Chemical Society, could lead to novel therapeutic approaches for these diseases. view more (2009-11-06)
HIV and malaria combine to adversely affect pregnant women and their infants
University of Toronto researchers have uncovered the basis by which pregnant women protect themselves against malaria and have also discovered how the HIV virus works to counteract this defence. The research could lead to improved vaccines for pregnant women in malaria-ravished regions. view more (2007-05-30)
Re-awakening old genes to help in the fight against HIV
A new vaginal cream containing a reawakened protein could someday prevent the transmission of HIV. view more (2009-04-28)
Several minute intermediate stage in virus-cell fusion discovered; opportunity for drug development
o ignite a life-threatening infection in the body, a virus such as HIV invades body cells by first merging, or fusing, with the cell's outer membrane. Once inside the cell, the invading microbe's genetic material takes over, turning the 'host' cell into a factory to produce more copies of the virus, which then spill out to invade other cells in... view more... (2005-06-09)
Polio Vaccination Strategies Assessed as Eradication Nears
Polio is on track to become only the second disease ever eradicated. In two studies in the Dec. 15 issue of The Journal of Infectious Diseases, now available online, scientists are working to ensure that once it is gone, it stays gone. view more (2005-12-20)
HIV patients at greater risk for bone fractures
HIV-infected patients have a higher prevalence of fractures than non HIV-infected patients, across both genders and critical fracture sites according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM). view more (2008-08-28)
Clues to ensuring anti-HIV drugs are taken in Africa
HIV-infected patients in the African country of Tanzania were more likely to stop taking their medications and to fail treatment if they had to pay for the drugs themselves. view more (2007-10-23)
Even older women at high risk have little interest in being tested for HIV, study finds
Few older women were interested in being tested for the virus that causes AIDS despite having significant risk factors for lifetime exposure, according to a study published in the July/August edition of the Journal of Women's Health. view more (2007-08-08)
Discovery of the origin of the Simian Immunodeficiency Virus (SIV) in the chimpanzee
The origin of HIV-1 (human immunodeficiency virus-1), responsible for the global Aids pandemic, has been a live issue in the scientific community for many years. It is now recognized that HIV-1 in the human population results from cross-species transmission of SIVcpz, from chimpanzees (Pan troglodytes troglodytes) to humans, most likely through... view more... (2003-06-16)
Researchers discover new battleground for viruses and immune cells
Vaccines have led to many of the world's greatest public health triumphs, but many deadly viruses, such as HIV, still elude the best efforts of scientists to develop effective vaccines against them. view more (2008-02-07)
Europe becoming complacent over HIV prevention
Rising levels of gonorrhoea and syphilis across western Europe since 1995 imply that complacency over HIV prevention efforts may have set in among individuals and some governments, argue researchers in this week's BMJ. Angus Nicoll and Francoise Hamers examined national trends in diagnosed HIV infections, gonorrhoea, and infectious syphilis from... view more... (2002-05-28)
New Stanford list of HIV mutations vital to tracking AIDS epidemic
In a collaborative study with the World Health Organization and seven other laboratories, researchers at the Stanford University School of Medicine have compiled a list of 93 common mutations of the AIDS virus associated with drug resistance that will be used to track future resistance trends throughout the world. view more (2009-03-06)
U of M study shows why treatment isn't effective for HIV
University of Minnesota researchers have answered a key question as to why antiretroviral therapy isn't effective in restoring immunity in HIV-infected patients. view more (2008-08-06)
Two More Potential HIV Vaccines
Despite long-term researchers' efforts, efficient human immunodeficienct virus (HIV) vaccine has not been created yet. However, researchers are not giving up their attempts. Russian biologists are now proposing two more vaccine options based on DNA that encodes human immunodeficienct virus proteins. Experience proves that traditional ways of... view more... (2004-05-17)
Discovery in plant virus may help prevent HIV and similar viruses
In a study that could lead to new ways to prevent infection by human immunodeficiency virus (HIV) and similar organisms, Purdue University researchers have been able to genetically modify a plant to halt reproduction of a related virus. view more (2007-08-01)
Defense peptide found in primates may block some human HIV transmissions
As primates evolved 7 million years ago, the more advanced species stopped making a protein that University of Central Florida researchers believe can effectively block the HIV-1 virus from entering and infecting blood cells. view more (2006-08-10)
HIV/AIDS: European Research provides clear proof that HIV virus cannot pass through condoms
Questions have arisen recently over whether the HIV virus can or cannot pass through pores in latex condoms. EU research projects provide extensive proof that this is not the case: if properly used, condoms are safe. Over the last 15 years, the Commission has supported about a dozen research initiatives in this field across Europe, as well as in... view more... (2003-10-20)
Maternal HIV-1 treatment protects against transmission to newborns
Mothers receiving highly active antiretroviral therapy (HAART) to treat HIV-1 infection are less likely than untreated mothers to transmit the virus to their newborns through breastfeeding. view more (2009-10-19)
Research promising for cystic fibrosis
New U of T research holds promise for developing innovative therapies against cystic fibrosis and may also serve as a model for future therapies against the HIV virus. view more (2008-03-19)
MRC Study Shows Highly Active Anti-retroviral Therapy Dramatically Cuts Deaths From AIDS
A dramatic increase in life expectancy for people infected with HIV has been achieved since the introduction of Highly Active Anti-Retroviral Therapy (HAART), say Medical Research Council (MRC) scientists today (Friday 17 October 2003). New research conducted at the MRC Clinical Trials Unit in London and published in this week's issue of The... view more... (2003-10-16)
|
|
| Page
9 of
73 |
1455 Results |
|
|
|
Sort By:
Page Views | Date |
|
